Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Buy | $302K | SEC | |
| Other | $3.8M | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $711K | SEC | |
| ExerciseD | $0 | SEC | |
| Other | $11.6M | SEC | |
| Exercise | $4.7M | SEC | |
| AwardD | $0 | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $0 | SEC | |
| Other | $6.9M | SEC | |
| Buy | $104.3K | SEC | |
| Exercise | $638.5K | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $1.6M | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $118.7K | SEC | |
| Buy | $60.8K | SEC | |
| Buy | $98.9K | SEC | |
| Other | $5.5M | SEC | |
| Exercise | — | SEC | |
| ExerciseD | $0 | SEC | |
| ExerciseD | $0 | SEC | |
| AwardD | $0 | SEC | |
| Other | $2.5M | SEC |